Cerebrovascular Insufficiency
Also known as: Insufficiency cerebrovascular
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB08941 | Isoxsuprine | A beta-adrenergic agonist used in the symptomatic treatment of cerebrovascular insufficiency, peripheral vascular disease of arteriosclerosis obliterans, thromboangiitis obliterans (Buerger's disease) and Raynaud's disease. |
| DB00699 | Nicergoline | An ergot derivative use for the treatment of symptoms associated with cerebrovascular abnormalities. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB00699 | Nicergoline | Alpha-1A adrenergic receptor | target |
| DB00699 | Nicergoline | Cytochrome P450 2D6 | enzyme |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB01381 | Ginkgo biloba | 4 | Completed | 1 |